Search

everythinglearnresearchcommunity

for

Search:↓

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Accurate diagnosis is crucial for effective treatment of hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

CCCA can affect both genders and all ages, and it has a genetic component.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Enlarged sweat gland ducts may indicate scarring hair loss.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

DNA analysis can help tailor alopecia treatment.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Some people experienced hair loss after mesotherapy treatments for hair loss.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.